Catheter ablation versus medical therapy for atrial fibrillation : Penny-wise Pound-foolish
© 2021 Wiley Periodicals LLC..
Catheter ablation for atrial fibrillation has emerged as a mainstay for the management of atrial fibrillation. It has been shown to be clinically effective and cost-effective in multiple trials.
| Errataetall: |
CommentOn: J Cardiovasc Electrophysiol. 2022 Feb;33(2):164-175. - PMID 34897897 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:33 |
|---|---|
| Enthalten in: |
Journal of cardiovascular electrophysiology - 33(2022), 2 vom: 15. Feb., Seite 176-177 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kowlgi, Gurukripa N [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Anti-Arrhythmia Agents |
|---|
| Anmerkungen: |
Date Completed 16.03.2022 Date Revised 16.03.2022 published: Print-Electronic CommentOn: J Cardiovasc Electrophysiol. 2022 Feb;33(2):164-175. - PMID 34897897 Citation Status MEDLINE |
|---|
| doi: |
10.1111/jce.15316 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM334343496 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM334343496 | ||
| 003 | DE-627 | ||
| 005 | 20231225223517.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/jce.15316 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1114.xml |
| 035 | |a (DE-627)NLM334343496 | ||
| 035 | |a (NLM)34897873 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kowlgi, Gurukripa N |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Catheter ablation versus medical therapy for atrial fibrillation |b Penny-wise Pound-foolish |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 16.03.2022 | ||
| 500 | |a Date Revised 16.03.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: J Cardiovasc Electrophysiol. 2022 Feb;33(2):164-175. - PMID 34897897 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2021 Wiley Periodicals LLC. | ||
| 520 | |a Catheter ablation for atrial fibrillation has emerged as a mainstay for the management of atrial fibrillation. It has been shown to be clinically effective and cost-effective in multiple trials | ||
| 650 | 4 | |a Editorial | |
| 650 | 4 | |a Comment | |
| 650 | 4 | |a United Kingdom | |
| 650 | 4 | |a antiarrhythmic drugs | |
| 650 | 4 | |a atrial fibrillation | |
| 650 | 4 | |a catheter ablation | |
| 650 | 4 | |a cost-effectiveness | |
| 650 | 7 | |a Anti-Arrhythmia Agents |2 NLM | |
| 700 | 1 | |a Deshmukh, Abhishek J |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of cardiovascular electrophysiology |d 1996 |g 33(2022), 2 vom: 15. Feb., Seite 176-177 |w (DE-627)NLM074905481 |x 1540-8167 |7 nnns |
| 773 | 1 | 8 | |g volume:33 |g year:2022 |g number:2 |g day:15 |g month:02 |g pages:176-177 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/jce.15316 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 33 |j 2022 |e 2 |b 15 |c 02 |h 176-177 | ||